FGD1 antibody (C-Term)
Quick Overview for FGD1 antibody (C-Term) (ABIN927334)
Target
See all FGD1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity
- Mouse (Murine), Rat (Rattus), Cow (Bovine), Dog (Canine)
-
Purification
- Purified
-
Immunogen
- FGD1 antibody was raised in rabbit using the C terminal of FGD1 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
FGD1 Blocking Peptide, (ABIN5613572), is also available for use as a blocking control in assays to test for specificity of this FGD1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- FGD1 (FYVE, RhoGEF and PH Domain Containing 1 (FGD1))
-
Alternative Name
- FGD1
-
Background
- FGD1 contains Dbl (DH) and pleckstrin (PH) homology domains. It can bind specifically to the Rho family GTPase Cdc42Hs and stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. FGD1 has an essential role in embryonic development, and FGD1 gene mutations result in the human developmental disorder, Aarskog-Scott syndrome. Synonyms: Polyclonal FGD1 antibody, Anti-FGD1 antibody, FYVE, RhoGEF and PH domain containing 1, faciogenital dysplasia antibody.
-
Pathways
- Neurotrophin Signaling Pathway
Target
-